SANIFIT
Company

Last deal

$19.34M
Local Amount - EUR 17M

Amount

Convertible Note

Stage

26.06.2019

Date

3

all rounds

$128.26M

Total amount

date founded

Financing round

General

About Company
SANIFIT is a biotechnology company that develops treatments for patients with calcification disorders.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2007

Number of employees

Company Type

For Profit

Last funding type

Convertible Note

IPO status

Private

Description

SANIFIT develops treatments for calcification disorders.
Contacts

Contact Email

Phone number

Social url

Similar Companies
1000
Bio-Cancer Treatment

Bio-Cancer Treatment

Bio-Cancer Treatment is developing innovative biologics for the treatment of cancer and autoimmune disorders.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Medical

Location

Sha Tin, Hong Kong
Edesa Biotech

Edesa Biotech

Edesa Biotech develops treatments for dermatological and anorectal diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Medical

Location

Markham, ON, Canada

total rounds

7

total raised

$66.6M
VersaPeutics

VersaPeutics

VersaPeutics is a biotech startup focused on treating nervous system disorders.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Biotechnology, Medical

Location

San Diego, CA, USA

total rounds

3

total raised

$3.75M
Nacuity Pharmaceuticals

Nacuity Pharmaceuticals

Nacuity Pharmaceuticals aims to develop a breakthrough treatment for retinitis pigmentosa and other ophthalmological indications.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Biotechnology, Pharmaceuticals

Location

Fort Worth, TX, USA

total rounds

3

total raised

$18.47M
M&A Details
1

Transaction name

Acquired by

Vifor Pharma

announced date

22.11.2021

Financials

Funding Rounds
5
3

Number of Funding Rounds

$128.26M

Money Raised

Their latest funding was raised on 26.06.2019. Their latest round Convertible Note

Date 
Funding Round 
Investors 
Money Raised 
Lead 
26.06.2019
$19.34M
Local Amount - EUR 17M
26.06.2019
9
$62.78M
Local Amount - EUR 55.2M
08.09.2015
8
$41.01M
Local Amount - EUR 36.6M
Caixa Capital Risc

Caixa Capital Risc

Caixa Capital Risc invests in innovative early-stage companies in Spain and Portugal.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

Barcelona, Spain

count Of Investments

164

count Of Exists

29
Ysios Capital

Ysios Capital

Ysios Capital provides venture capital funding to Spanish life science companies.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Venture Capital, Biotechnology

Location

Donostia-San Sebastian, Gipuzkoa, Spain

count Of Investments

63

count Of Exists

9
Co-Investors
Investors
11
2

Number of lead investors

11

Number of investors

Investor 
Lead 
Round 
Partners 
No
Series C, Series D
No
Series C, Series D
No
Series C
Andera Partners

Andera Partners

Andera Partners is a venture capital firm that invests in various sectors.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Venture Capital

Location

Paris, France

total rounds

1

total raised

$48.5M

count Of Investments

169

count Of Exists

39
Gilde Healthcare

Gilde Healthcare

Gilde Healthcare is a European healthcare investor that specializes in lower mid-market buyouts and later stage venture.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Health Care, Venture Capital, Financial Services

Location

Utrecht, Netherlands

count Of Investments

89

count Of Exists

22
Baxter Ventures

Baxter Ventures

Baxter Ventures invests in innovative healthcare companies to improve patient care and maximize value for investors and entrepreneurs.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Venture Capital

Location

Deerfield, IL, USA

count Of Investments

15

count Of Exists

3

People

Founders
1
Joan Perelló
Joan Perelló

Joan Perelló

Joan is CEO and co-founder of Sanifit. He has led several financing rounds at Sanifit totalling >€40m, including most recently a series raised Euro 37m. He served as Chief Scientific Officer at Sanifit from 2004 to 2013, and from 2009 to 2013 he pioneered the international development of Sanifit’s lead candidate, SNF 472, from academia to its clinical evaluation in patients suffering from calciphylaxis and ESRD. He is President of the Balearic Cluster of Biotechnology and Biomedicine and Vice-Dean at the Official College of Chemists in the Balearic Islands, Spain. Joan has earned several research and innovation prizes, including the National Prize for the best Doctoral Thesis in Lithiasis, awarded by Ferrer Pharma in 2005. He is co-author of over 40 peer-reviewed international publications, co-inventor of 9 international patents, and has participated in over 30 research projects, half of which as Principal Investigator. Joan holds an MSc in Chemistry with first class honours, and earned his PhD from the University of the Balearic Islands, Spain, where he teaches Analytical and Clinical Chemistry as Adjunct Lecturer.

current job

SANIFIT
SANIFIT

organization founded

1

Joan Perelló

Employee Profiles
5
Joan Perelló

Joan Perelló

CEO and co-founder

Damià Tormo

Damià Tormo

Directors

Guy P. Nohra

Guy P. Nohra

Directors

Activity

Recent News
1